Panacea Life Sciences HoldingsPLSH +3.64% Gross Margin % is 94.00% as of Sep. 2025, which is 272% above its 10-year median of 25.30. The stock has 6 warning signs investors should review. Among 938 Drug Manufacturers companies, Panacea Life Sciences Holdings ranks better than 67.48% on this metric.
Panacea Life Sciences Holdings (OTCPK:PLSH) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Panacea Life Sciences Holdings had a gross margin of 94.00% for the quarter that ended in Sep. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Panacea Life Sciences Holdings Gross Margin % Related Terms
Panacea Life Sciences Holdings Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Panacea Life Sciences Holdings Gross Margin % Chart
PLSH vs NPHC, OWPC, CBDY: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Panacea Life Sciences Holdings Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Panacea Life Sciences Holdings's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Panacea Life Sciences Holdings (PLSH) has a Gross Margin % of 94.00% as of Sep. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Panacea Life Sciences Holdings and its competitors. This is 272% above median its historical median of 25.30. Over the past decade, Panacea Life Sciences Holdings' Gross Margin % has ranged from 22.14 to 59.12. According to the industry distribution chart, Panacea Life Sciences Holdings ranks #305 out of 938 companies in the Drug Manufacturers industry, placing it in the top 32.5%.
Is Panacea Life Sciences Holdings' Gross Margin % too high?
Panacea Life Sciences Holdings' current Gross Margin % of 94.00% is 272% above median its 10-year median of 25.30. Over the past 10 years, this metric has ranged from a low of 22.14 to a high of 59.12. The Drug Manufacturers industry median Gross Margin % is 48.44. Panacea Life Sciences Holdings' value of 94.00% is 94.1% above this industry median. Based on the distribution chart, Panacea Life Sciences Holdings ranks #305 out of 938 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Panacea Life Sciences Holdings' Gross Margin % compare to NPHC and OWPC?
According to the Drug Manufacturers industry distribution chart, Panacea Life Sciences Holdings ranks #305 out of 938 companies for Gross Margin %. This puts Panacea Life Sciences Holdings in the upper half of its industry. The industry median Gross Margin % is 48.44. Panacea Life Sciences Holdings' value of 94.00% is 94.1% above this benchmark. Historically, Panacea Life Sciences Holdings' own Gross Margin % has ranged from 22.14 to 59.12 over the past decade. While the company's 10-year median is 25.30 vs. the industry median of 48.44, Panacea Life Sciences Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Panacea Life Sciences Holdings's current Gross Margin % of 94.00% is 94.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Panacea Life Sciences Holdings and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Panacea Life Sciences Holdings's current Gross Margin % is 94.00%, which is 272% above median its own 10-year median of 25.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current Gross Margin % of 94.00%. The current Gross Margin % is 94.00%, which is 272% above median its 10-year median of 25.30 and 94.1% above the Drug Manufacturers industry median of 48.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current Gross Margin % is 94.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Panacea Life Sciences Holdings Business Description
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLSH has been successfully added to your 